Fucoxanthin inhibits tumour-related lymphangiogenesis and growth of breast cancer.

导出 OA

翻译打印收藏纠错

第一作者： Jia,Wang

第一单位： Regenerative Medicine Center, The First Affiliated Hospital of Dalian Medical University, Dalian, China.;Department of Biotechnology, Dalian Medical University, Dalian, China.;Department of Critical Care Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China.

作者： Jia,Wang ^[1] ; Yanhong,Ma ^[2] ; Jingshi,Yang ^[2] ; Lu,Jin ^[2] ; Zixiang,Gao ^[2] ; Lingyun,Xue ^[3] ; Lin,Hou ^[4] ; Linlin,Sui ^[2] ; Jing,Liu ^[5] ; Xiangyang,Zou ^[2]

作者单位： Regenerative Medicine Center, The First Affiliated Hospital of Dalian Medical University, Dalian, China.;Department of Biotechnology, Dalian Medical University, Dalian, China.;Department of Critical Care Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China. ^[1] Department of Biotechnology, Dalian Medical University, Dalian, China. ^[2] INNOBIO Corporation Limited, Dalian, China. ^[3] College of Life Sciences, Liaoning Normal University, Dalian, China. ^[4] Regenerative Medicine Center, The First Affiliated Hospital of Dalian Medical University, Dalian, China. ^[5]

关键词 MDA-MB-231 cells fucoxanthin lymphatic metastasis tumour-induced lymphangiogenesis